EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 18 April 2024. Database contains 4821 unique substances/entries.

Filter the list

Showing 1,751 - 1,800 of 4,821 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC	EU REACH: List of SVHC
Creosote oil, high-boiling distillate; Wash Oil [The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41°F).] The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5°C (41°F).	274-565-9	70321-79-8	Carc. 1B
Creosote oil, low-boiling distillate; Wash Oil [he low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 o C (100 oF).] The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38°C (100°F).	274-566-4	70321-80-1	Carc. 1B
Creutzfeldt-Jakob disease	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Crimean-Congo haemorrhagic fever	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
crimidine (ISO);2-chloro-6-methylpyrimidin-4- yldimethylamine	208-622-6	535-89-7	Acute Tox. 2
crotonaldehyde; 2-butenal	224-030-0	4170-30-3	Flam. Liq. 2; Muta. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate	231-720-5	7700-17-6	Acute Tox. 3
crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate	206-083-1	299-86-5	Acute Tox. 4
Cryptococcus neoformans var. gattii	-	-		F Fungi
Cryptococcus neoformans var. neofonnans	-	-		F Fungi
Cryptosporidium parvum	-	-		P Parasites
Cryptosporidium spp.	-	-		P Parasites
cumene	202-704-5	98-82-8	Flam. Liq. 3; Asp. Tox. 1; STOT SE 3
cyanamide; carbanonitril	206-992-3	420-04-2	Carc. 2; Repr. 2; Acute Tox. 3; STOT RE 2; Skin Corr. 1; Skin Sens. 1; Eye Dam. 1
cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5- triazine-2-ylamino)-2-methylpropionitrile	244-544-9	21725-46-2	Acute Tox. 4
cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate	620-377-0	13067-93-1	Acute Tox. 3; STOT SE 1; Acute Tox. 4; Eye Irrit. 2
cyanophos (ISO); O-4-cyanophenyl O,O-dimethyl phosphorothioate	220-130-3	2636-26-2	Acute Tox. 4
cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate	223-099-4	3734-95-0	Acute Tox. 2; Acute Tox. 3
cyclanilide (ISO); 1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid CSDCA	419-150-7	113136-77-9	Acute Tox. 4
cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione	427-230-8	5571-36-8	Repr. 1B; STOT RE 2
cyclohexadeca-1,9-diene	431-730-1	4277-06-9	Skin Irrit. 2; Skin Sens. 1
cyclohexane	203-806-2	110-82-7	Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3
cyclohexane-1,2-dicarboxylic anhydride	201-604-9	85-42-7	Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1		yes
cyclohexanol	203-630-6	108-93-0	Acute Tox. 4; STOT SE 3; Skin Irrit. 2
cyclohexanone	203-631-1	108-94-1	Flam. Liq. 3; Acute Tox. 4
cyclohexanone, peroxide [> 91 % solution];cyclohexanone, peroxide [≤ 91 % solution]	235-527-7	12262-58-7	Org. Perox. A; Skin Corr. 1B; Acute Tox. 4
cyclohexanone, peroxide [> 91 % solution];cyclohexanone, peroxide [≤ 91 % solution]	235-527-7	12262-58-7	Org. Perox. C; Acute Tox. 4; Skin Corr. 1B
cycloheximide (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5- dimethyl-2-oxocyclohexyl]-2- hydroxyethyl}piperidine-2,6- dione	200-636-0	66-81-9	Muta. 2; Repr. 1B; Acute Tox. 2
cyclohexyl acrylate	221-319-3	3066-71-5	STOT SE 3; Skin Irrit. 2
cyclohexylamine	203-629-0	108-91-8	Flam. Liq. 3; Repr. 2; Acute Tox. 4; Skin Corr. 1B
cyclohexyldimethoxymethylsilane CHMMS; CHMS; DYNASYLAN 9407; Z-6187	402-140-1	17865-32-6	Skin Irrit. 2
cyclohexylidene hydroperoxide [> 91 % solution];cyclohexylidene hydroperoxide [≤ 91 % solution]	220-279-4	2699-11-8	Org. Perox. C; Acute Tox. 4; Skin Corr. 1B
cyclohexylidene hydroperoxide [> 91 % solution];cyclohexylidene hydroperoxide [≤ 91 % solution]	220-279-4	2699-11-8	Org. Perox. A; Skin Corr. 1B; Acute Tox. 4
cyclooct-4-en-1-yl methyl carbonate VIOLIFF	401-620-8	87731-18-8	Skin Sens. 1
cyclopentane	206-016-6	287-92-3	Flam. Liq. 2
cyclopentane-1,2,3,4-tetracarboxylic dianhydride	227-964-7	6053-68-5	Eye Irrit. 2; STOT SE 3
cyclopentanone	204-435-9	120-92-3	Flam. Liq. 3; Eye Irrit. 2; Skin Irrit. 2
cyclopentyl 2-phenylethyl ether	428-340-9	238088-70-5	Skin Irrit. 2
cyclopentyl chloroformate CHLOROFORMIATE DE CYCLOPENTYLE; CYCLOPENTYLCHLORFORMIAT	411-460-0	50715-28-1	Flam. Liq. 3; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
cyclopropane	200-847-8	75-19-4	Flam. Gas 1; Press. Gas
Cyclospora cayetanensis	-	-		P Parasites
cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one	405-230-9	101205-02-1	Repr. 2
cyflumetofen (ISO); 2-methoxyethyl (RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate	642-974-5	400882-07-7	Carc. 2; Skin Sens. 1A
cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin	269-855-7	68359-37-5	Acute Tox. 2; Acute Tox. 3
cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin	269-855-7	68359-37-5	Acute Tox. 2
cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide	236-049-1	13121-70-5	Acute Tox. 4
cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide	261-043-0	57966-95-7	Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1
cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; cypermethrin cis/trans +/- 40/60;cypermethrin cis/trans +/-80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS;3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	257-842-9	52315-07-8	Acute Tox. 4; STOT SE 3; STOT RE 2
cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; cypermethrin cis/trans +/- 40/60;cypermethrin cis/trans +/-80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS;3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	257-842-9	52315-07-8	Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl) butan-2-ol	619-020-1	94361-06-5	Repr. 1B; Acute Tox. 3; STOT RE 2

Showing 1,751 - 1,800 of 4,821 results.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 18 April 2024. Database contains 4821 unique substances/entries.

Footer Nav Items